Literature DB >> 10477722

Identification of a 14-3-3 binding sequence in the common beta chain of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors that is serine-phosphorylated by GM-CSF.

F C Stomski1, M Dottore, W Winnall, M A Guthridge, J Woodcock, C J Bagley, D T Thomas, R K Andrews, M C Berndt, A F Lopez.   

Abstract

The common beta chain (beta(c)) of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors is the major signaling subunit of these receptors coupling ligand binding to multiple biological activities. It is thought that these multiple functions arise as a consequence of the recruitment of specific signaling molecules to tyrosine-phosphorylated residues in the cytoplasmic domain of beta(c). However, the contribution of serine phosphorylation in beta(c) to the recruitment of signaling molecules is not known. We show here the identification of a phosphoserine motif in the cytoplasmic domain of beta(c) that interacts with the adaptor protein 14-3-3zeta. Coimmunoprecipitation and pull-down experiments with a glutathione S-transferase (GST):14-3-3zeta fusion protein showed that 14-3-3 directly associates with beta(c) but not the GM-CSF receptor alpha chain. C-terminal truncation mutants of beta(c) further showed that a region between amino acids 544 and 626 in beta(c) was required for its association with 14-3-3zeta. This region contains the sequence (582)HSRSLP(587), which closely resembles the RSXSXP (where S is phosphorylated) consensus 14-3-3 binding site identified in a number of signaling molecules, including Raf-1. Significantly, substitution of (582)HSRSLP(587) for EFAAAA completely abolished interaction of beta(c) with GST-14-3-3zeta. Furthermore, the interaction of beta(c) with GST-14-3-3 was greatly reduced in the presence of a peptide containing the 14-3-3 binding site, but only when (585)Ser was phosphorylated. Direct binding experiments showed that the peptide containing phosphorylated (585)Ser bound 14-3-3zeta with an affinity of 150 nmol/L. To study the regulation of (585)S phosphorylation in vivo, we raised antibodies that specifically recognized (585)Ser-phosphorylated beta(c). Using these antibodies, we showed that GM-CSF stimulation strongly upregulated (585)Ser phosphorylation in M1 myeloid leukemic cells. The proximity of the SHC-binding site ((577)Tyr) to the 14-3-3-binding site ((582)HSRSLP(587)) and their conservation between mouse, rat, and human beta(c) but not in other cytokine receptors suggest that they form a distinct motif that may subserve specialized functions associated with the GM-CSF, IL-3, and IL-5 receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477722

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Proteasomal regulation of betac signaling reveals a novel mechanism for cytokine receptor heterotypic desensitization.

Authors:  M Martinez-Moczygemba; D P Huston
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 2.  Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants.

Authors:  Alastair Aitken
Journal:  Plant Mol Biol       Date:  2002-12       Impact factor: 4.076

3.  miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta.

Authors:  Duonan Yu; Camila O dos Santos; Guowei Zhao; Jing Jiang; Julio D Amigo; Eugene Khandros; Louis C Dore; Yu Yao; Janine D'Souza; Zhe Zhang; Saghi Ghaffari; John Choi; Sherree Friend; Wei Tong; Jordan S Orange; Barry H Paw; Mitchell J Weiss
Journal:  Genes Dev       Date:  2010-08-01       Impact factor: 11.361

4.  Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch.

Authors:  Mark A Guthridge; Jason A Powell; Emma F Barry; Frank C Stomski; Barbara J McClure; Hayley Ramshaw; Fernando A Felquer; Mara Dottore; Daniel T Thomas; Bik To; C Glenn Begley; Angel F Lopez
Journal:  EMBO J       Date:  2006-01-26       Impact factor: 11.598

5.  Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3zeta.

Authors:  David M Patrick; Cheng C Zhang; Ye Tao; Huiyu Yao; Xiaoxia Qi; Robert J Schwartz; Lily Jun-Shen Huang; Eric N Olson
Journal:  Genes Dev       Date:  2010-08-01       Impact factor: 11.361

Review 6.  Structural and functional hot spots in cytokine receptors.

Authors:  C J Bagley; J M Woodcock; M A Guthridge; F C Stomski; A F Lopez
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

7.  14-3-3:Shc scaffolds integrate phosphoserine and phosphotyrosine signaling to regulate phosphatidylinositol 3-kinase activation and cell survival.

Authors:  Emma F Barry; Fernando A Felquer; Jason A Powell; Lisa Biggs; Frank C Stomski; Andrea Urbani; Hayley Ramshaw; Peter Hoffmann; Matthew C Wilce; Michele A Grimbaldeston; Angel F Lopez; Mark A Guthridge
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

8.  A functional 14-3-3zeta-independent association of PI3-kinase with glycoprotein Ib alpha, the major ligand-binding subunit of the platelet glycoprotein Ib-IX-V complex.

Authors:  Fi-Tjen Mu; Robert K Andrews; Jane F Arthur; Adam D Munday; Susan L Cranmer; Shaun P Jackson; Frank C Stomski; Angel F Lopez; Michael C Berndt
Journal:  Blood       Date:  2008-02-25       Impact factor: 22.113

9.  Fibroblast growth factor receptor 2 phosphorylation on serine 779 couples to 14-3-3 and regulates cell survival and proliferation.

Authors:  Ana Lonic; Emma F Barry; Cindy Quach; Bostjan Kobe; Neil Saunders; Mark A Guthridge
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

10.  14-3-3ζ-TRAF5 axis governs interleukin-17A signaling.

Authors:  Jenna McGowan; Cara Peter; Joshua Kim; Sonam Popli; Brent Veerman; Jessica Saul-McBeth; Heather Conti; Shondra M Pruett-Miller; Saurabh Chattopadhyay; Ritu Chakravarti
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.